Search

Search

Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Home
...
Áreas de investigación Ciencias Biomédicas y Clínicas Oncología y carcinogénesis Objetivos moleculares
Áreas de investigación
Ciencias Biomédicas y Clínicas
Oncología y carcinogénesis
Objetivos moleculares
Tumores raros, objetivos reales: modelos derivados de pacientes para el descubrimiento y la validación de terapias de precisión

Tumores raros, objetivos reales: modelos derivados de pacientes para el descubrimiento y la validación de terapias de precisión

Nathan P Coussens ¹, Beverly A Teicher ²

Nathan P Coussens ¹, Beverly A Teicher ²

¹Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
²Molecular Pharmacology Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.

⁰Molecular Pharmacology Laboratory, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Expert Opinion on Therapeutic Targets +

|

21 de agosto de 2025

|

21 de agosto de 2025

Videos de Experimentos Relacionados

Contact us if these videos are not relevant.

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

See all related videos

Resumen

No abstract available on PubMed

Palabras clave:

Descubrimiento de drogas El gen de la fusión en el campo de la oncología Organoideas derivado del paciente Medicina de precisión Cáncer poco común tumor poco frecuente el sarcoma trasplante xenográfico

Videos de Experimentos Relacionados

Contact us Si estos videos no son relevantes.

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

See all related videos

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies